# 489MO A multicenter, single-arm, phase II trial of androgen deprivation therapy in combination with apalutamide in patients with high risk of recurrence after radical prostatectomy (ARES study)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/489mo-a-multicenter-single-arm-phase-ii-trial-of-androgen-deprivation-therapy-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Q. Zhang,L. Xu,X. Qiu,J. Zhuang,S. Zhang,C. Zhou,L. Xu,Haibo Xu,X. Wang,W. Liu,Xiaoyu Jia,H. Guo |
| Citations | 0 |
| DOI | 10.1016/j.annonc.2025.10.384 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W7116989461 |
| Type | article |
| Year | 2025 |

## Paper authors

- [H. Guo](https://scholariq.org/researchers/h-guo/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)

## Paper topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Prostate Cancer Diagnosis and Treatment](https://scholariq.org/topics/prostate-cancer-diagnosis-and-treatment/)
- [Urinary Bladder and Prostate Research](https://scholariq.org/topics/urinary-bladder-and-prostate-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.